Science News
from research organizations

Hormone therapy could enhance therapeutic effect of head, facial bone grafts

Date:
November 20, 2013
Source:
American Chemical Society
Summary:
Bone grafts, which are used to treat head injuries and birth defects, still pose major medical challenges, but scientists are reporting progress toward a new hormone therapy that could improve the outcomes of these surgeries.
Share:
       
FULL STORY

Bone grafts, which are used to treat head injuries and birth defects, still pose major medical challenges, but scientists are reporting progress toward a new hormone therapy that could improve the outcomes of these surgeries. Their study, which was conducted on mice, appears in the ACS journal Molecular Pharmaceutics.

Zulma Gazit at Cedars-Sinai Medical Center, Edward Schwarz from Rochester University and colleagues note that surgeons perform nearly 100,000 head and facial bone-grafting procedures every year to treat bone loss from disease, birth defects or traumatic injuries. Though this kind of reconstructive surgery dates back to ancient times, the options for implant materials remain limited. Doctors can remove bone from another part of a patient's body or use lab-made materials, but these methods can lead to serious complications. Currently, one of the preferred alternatives is to use bone grafts received from tissue banks, but they often don't join with the bone they're supposed to fix. Preliminary studies have shown that parathyroid hormone (PTH), a drug approved by the U.S. Food and Drug Administration to treat osteoporosis, helps repair fractures in long bones. The team wanted to see if PTH also would help head and facial donor grafts fuse into place.

They tested the hormone in mice with skull defects that they implanted with donor grafts. Daily short-term PTH treatment improved bone formation around the grafts and prevented scar tissue, which can interfere with graft integration, from forming. "These findings will aid in the development of an attractive bone graft, which is readily available, for use in craniofacial reconstruction," they say.


Story Source:

The above post is reprinted from materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Dmitriy Sheyn, Doron Cohn Yakubovich, Ilan Kallai, Susan Su, Xiaoyu Da, Gadi Pelled, Wafa Tawackoli, Galen Cook-Weins, Edward M. Schwarz, Dan Gazit, Zulma Gazit. PTH Promotes Allograft Integration in a Calvarial Bone Defect. Molecular Pharmaceutics, 2013; 131108084025002 DOI: 10.1021/mp400292p

Cite This Page:

American Chemical Society. "Hormone therapy could enhance therapeutic effect of head, facial bone grafts." ScienceDaily. ScienceDaily, 20 November 2013. <www.sciencedaily.com/releases/2013/11/131120112006.htm>.
American Chemical Society. (2013, November 20). Hormone therapy could enhance therapeutic effect of head, facial bone grafts. ScienceDaily. Retrieved August 3, 2015 from www.sciencedaily.com/releases/2013/11/131120112006.htm
American Chemical Society. "Hormone therapy could enhance therapeutic effect of head, facial bone grafts." ScienceDaily. www.sciencedaily.com/releases/2013/11/131120112006.htm (accessed August 3, 2015).

Share This Page: